NasdaqGS - Nasdaq Real Time Price USD

LivaNova PLC (LIVN)

43.82

+0.27

+(0.62%)

At close: May 15 at 4:00:01 PM EDT

LivaNova to Present at the Jefferies Global Healthcare Conference

LONDON, May 15, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York. The presentation will take place Thurs., June 5, at 3:10 p.m. Eastern Time.

Business Wire 20 hours ago

LIVN
+0.62%
LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances

LivaNova PLC (LIVN) reports robust organic revenue growth and strategic progress in key markets, despite facing financial challenges.

GuruFocus.com 8 days ago

LIVN
+0.62%
Are LivaNova PLC's (NASDAQ:LIVN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

It is hard to get excited after looking at LivaNova's (NASDAQ:LIVN) recent performance, when its stock has declined 28...

Simply Wall St. 8 days ago

LIVN
+0.62%
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 17.33% and 5.41%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 8 days ago

LIVN
+0.62%
LivaNova: Q1 Earnings Snapshot

LONDON (AP) — LivaNova PLC (LIVN) on Wednesday reported a loss of $327.3 million in its first quarter. The London-based company said it had a loss of $6.01 per share. Earnings, adjusted for one-time gains and costs, came to 88 cents per share.

Associated Press Finance 8 days ago

LIVN
+0.62%
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance

LONDON, May 07, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2025 and updated full-year 2025 guidance.

Business Wire 8 days ago

LIVN
+0.62%
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

LONDON, May 07, 2025--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced 12-month, top-line data from its OSPREY randomized controlled trial (RCT), evaluating outcomes with the aura6000™ System for the treatment of moderate to severe obstructive sleep apnea (OSA). At 12 months of therapy, the treatment arm responder rate was 65% with responders defined as those who realized at least a 50% improvement from the baseline apnea-hypopnea index (AHI) and an AHI v

Business Wire 8 days ago

LIVN
+0.62%
Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now?

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a look at where LivaNova PLC (NASDAQ:LIVN) stands against other best undervalued UK stocks to buy right now. The UK and Europe’s Performance in Q1 2025 The global markets entered 2025 […]

Insider Monkey 20 days ago

LIVN
+0.62%
What Is LivaNova PLC's (NASDAQ:LIVN) Share Price Doing?

LivaNova PLC ( NASDAQ:LIVN ), might not be a large cap stock, but it saw significant share price movement during recent...

Simply Wall St. 30 days ago

LIVN
+0.62%
LivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to Billionaires

We recently published a list of 10 Best UK Stocks to Buy According to Billionaires. In this article, we are going to take a look at where LivaNova PLC (NASDAQ:LIVN) stands against other best UK stocks to invest in. Like most of the world, the United Kingdom is also facing slower economic growth in 2025, […]

Insider Monkey last month

LIVN
+0.62%
LivaNova to Announce First-Quarter 2025 Results

LONDON, March 26, 2025--LivaNova PLC will host a conference call to discuss its first-quarter 2025 results on Wed., May 7, 2025, at 1 p.m. London time (8 a.m. Eastern Time).

Business Wire last month

LIVN
+0.62%
LivaNova (NASDAQ:LIVN) investors are sitting on a loss of 50% if they invested three years ago

As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio...

Simply Wall St. last month

LIVN
+0.62%
LivaNova's (NASDAQ:LIVN) Performance Is Even Better Than Its Earnings Suggest

Investors were underwhelmed by the solid earnings posted by LivaNova PLC ( NASDAQ:LIVN ) recently. Our analysis says...

Simply Wall St. 2 months ago

LIVN
+0.62%
Is LivaNova PLC (LIVN) the Best Medical Technology Stock to Buy According to Analysts?

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where LivaNova PLC (NASDAQ:LIVN) stands against the other medical technology stocks. Growth and Drivers of the Global MedTech Market The MedTech sector is crucial in healthcare, which concentrates […]

Insider Monkey 2 months ago

LIVN
+0.62%
LivaNova PLC Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

It's been a mediocre week for LivaNova PLC ( NASDAQ:LIVN ) shareholders, with the stock dropping 15% to US$40.93 in the...

Simply Wall St. 2 months ago

LIVN
+0.62%
LivaNova Full Year 2024 Earnings: EPS Beats Expectations

LivaNova ( NASDAQ:LIVN ) Full Year 2024 Results Key Financial Results Revenue: US$1.25b (up 8.7% from FY 2023). Net...

Simply Wall St. 2 months ago

LIVN
+0.62%
LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

LivaNova PLC (LIVN) reports robust organic revenue growth and strategic advancements, despite challenges in international markets and earnings per share decline.

GuruFocus.com 2 months ago

LIVN
+0.62%
LivaNova (LIVN) Tops Q4 Earnings Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 1.25% and 0.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

LIVN
+0.62%
LivaNova: Q4 Earnings Snapshot

The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 80 cents per share. The medical technology company posted revenue of $321.8 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $323.4 million.

Associated Press Finance 2 months ago

LIVN
+0.62%
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance

LONDON, February 25, 2025--LivaNova PLC today reported fourth-quarter and full-year 2024 results and issued full-year 2025 guidance.

Business Wire 2 months ago

LIVN
+0.62%

Performance Overview

Return	LIVN	S&P 500 (^GSPC)
YTD	-5.38%	+0.60%
1-Year	-30.66%	+11.47%
3-Year	-32.64%	+47.05%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

LivaNova PLC (LIVN)

LivaNova to Present at the Jefferies Global Healthcare Conference

LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances

Are LivaNova PLC's (NASDAQ:LIVN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova: Q1 Earnings Snapshot

LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now?

What Is LivaNova PLC's (NASDAQ:LIVN) Share Price Doing?

LivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to Billionaires

LivaNova to Announce First-Quarter 2025 Results

LivaNova (NASDAQ:LIVN) investors are sitting on a loss of 50% if they invested three years ago

LivaNova's (NASDAQ:LIVN) Performance Is Even Better Than Its Earnings Suggest

Is LivaNova PLC (LIVN) the Best Medical Technology Stock to Buy According to Analysts?

LivaNova PLC Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

LivaNova Full Year 2024 Earnings: EPS Beats Expectations

LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ...

LivaNova (LIVN) Tops Q4 Earnings Estimates

LivaNova: Q4 Earnings Snapshot

LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance

Performance Overview